Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus
人诱导多能干细胞来源的肝细胞系作为宿主与乙型肝炎病毒相互作用的新模型
基本信息
- 批准号:15K15285
- 负责人:
- 金额:$ 2.33万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Challenging Exploratory Research
- 财政年份:2015
- 资助国家:日本
- 起止时间:2015-04-01 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
项目成果
期刊论文数量(38)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Expression of IFN lambda 4 in liver is closely associated with non-response to antiviral therapy through the regulation of basal expression of ISGs in chronic hepatitis C patients but not in hepatitis B.
肝脏中 IFN lambda 4 的表达通过调节慢性丙型肝炎患者 ISG 的基础表达与抗病毒治疗无反应密切相关,但在乙型肝炎中则不然。
- DOI:
- 发表时间:2015
- 期刊:
- 影响因子:0
- 作者:Murakawa M;Asahina Y;Kawai-Kitahata F;Nagata H;Kaneko S;Nitta S;Watanabe T;Itsui Y;Nakagawa M;Kakinuma S;Iijima S;Tanaka Y;Watanabe M;Tanaka Y
- 通讯作者:Tanaka Y
Effects of Resistance-Associated NS5A Mutations in Hepatitis C Virus on Viral Production and Susceptibility to Antiviral Reagents.
- DOI:10.1038/srep34652
- 发表时间:2016-10-05
- 期刊:
- 影响因子:4.6
- 作者:Nitta S;Asahina Y;Matsuda M;Yamada N;Sugiyama R;Masaki T;Suzuki R;Kato N;Watanabe M;Wakita T;Kato T
- 通讯作者:Kato T
Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment Failure.
- DOI:10.1371/journal.pone.0165339
- 发表时间:2016
- 期刊:
- 影响因子:3.7
- 作者:Itakura J;Kurosaki M;Hasebe C;Osaki Y;Joko K;Yagisawa H;Sakita S;Okushin H;Satou T;Hisai H;Abe T;Tsuji K;Tamada T;Kobashi H;Mitsuda A;Ide Y;Ogawa C;Tsuruta S;Takaguchi K;Murakawa M;Asahina Y;Enomoto N;Izumi N
- 通讯作者:Izumi N
Human induce pluripotent stem cell-dereived hepatic progenitor-like cells and hepatocyte-like cells as a model for interaction between hepatitis B virus and host cells.
人类诱导多能干细胞来源的肝祖细胞样细胞和肝细胞样细胞作为乙型肝炎病毒与宿主细胞之间相互作用的模型。
- DOI:
- 发表时间:2015
- 期刊:
- 影响因子:0
- 作者:Kaneko S;Kakinuma S;Asahina Y;Kamiya A;Nitta S;Tsunoda T;Miyosi M;Nagata H;Goto F;Otani S;Murakawa M;Kawai-Kitahata F;Itsui Y;Nakagawa M;Azuma S;Watanabe M
- 通讯作者:Watanabe M
Effects of resistance mutations of NS5A inhibitor on viral production and susceptibility to anti-HCV reagents in recombinant hepatitis C viruses with NS5A of genotype 1b.
NS5A 抑制剂耐药突变对基因型 1b NS5A 重组丙型肝炎病毒中病毒产生和抗 HCV 试剂敏感性的影响。
- DOI:
- 发表时间:2015
- 期刊:
- 影响因子:0
- 作者:Nitta S;Asahina Y;Wakita T;Kato T
- 通讯作者:Kato T
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Asahina Yasuhiro其他文献
Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy
接受核酸类似物治疗的慢性乙型肝炎患者脂肪肝和纤维化对肝细胞癌发展的影响
- DOI:
10.1111/jvh.13805 - 发表时间:
2023 - 期刊:
- 影响因子:2.5
- 作者:
Keitoku Taisei;Asahina Yasuhiro;et al. - 通讯作者:
et al.
Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver mice
NS3/4A抑制剂、NS5B抑制剂和非选择性抗病毒药物两种药物的组合对人源化肝小鼠中NS5A-P32缺失的丙型肝炎病毒有效
- DOI:
10.1007/s00535-018-01541-x - 发表时间:
2019 - 期刊:
- 影响因子:6.3
- 作者:
Doi Akira;Hikita Hayato;Kai Yugo;Tahata Yuki;Saito Yoshinobu;Nakabori Tasuku;Yamada Ryoko;Kodama Takahiro;Sakamori Ryotaro;Murayama Asako;Nitta Sayuri;Asahina Yasuhiro;Suemizu Hiroshi;Tatsumi Tomohide;Kato Takanobu;Takehara Tetsuo - 通讯作者:
Takehara Tetsuo
本邦におけるSSBEの発癌ポテンシャルに対する遺伝学的検討(LSBE, EACとの比較)uate risk factors of carcinogenesis?
日本SSBE致癌潜力的遗传学研究(与LSBE、EAC比较)?确定致癌的危险因素?
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
Nitta Sayuri;Takahashi Kazuaki;Kawai‐Kitahata Fukiko;Tsuchiya Jun;Sato Ayako;Miyoshi Masato;Murakawa Miyako;Itsui Yasuhiro;Nakagawa Mina;Azuma Seishin;Kakinuma Sei;Watanabe Mamoru;Asahina Yasuhiro;平井亮佑,衣笠秀明,平岡佐規子;①徳長鎮,②沖元謙一郎,③加藤直也 - 通讯作者:
①徳長鎮,②沖元謙一郎,③加藤直也
Time course alterations of virus sequences and immunoglobulin titers in a chronic hepatitis E patient
慢性戊型肝炎患者病毒序列和免疫球蛋白滴度的时程变化
- DOI:
10.1111/hepr.13480 - 发表时间:
2020 - 期刊:
- 影响因子:4.2
- 作者:
Nitta Sayuri;Takahashi Kazuaki;Kawai‐Kitahata Fukiko;Tsuchiya Jun;Sato Ayako;Miyoshi Masato;Murakawa Miyako;Itsui Yasuhiro;Nakagawa Mina;Azuma Seishin;Kakinuma Sei;Watanabe Mamoru;Asahina Yasuhiro - 通讯作者:
Asahina Yasuhiro
Development of Hepatocellular Carcinoma after Interferon Therapy in Chronic Hepatitis C
慢性丙型肝炎干扰素治疗后肝癌的发展
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:4.6
- 作者:
N. Izumi;Asahina Yasuhiro;M. Kurosaki;Y. Onuki;Yuki Nishimura;K. Inoue;K. Ueda;K. Tsuchiya;H. Nakanishi;M. Uchihara;S. Miyake - 通讯作者:
S. Miyake
Asahina Yasuhiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Asahina Yasuhiro', 18)}}的其他基金
Analyses of genomic alteration and mechanisms responsible for hepatocarcinogenesis using deep sequencing and human iPS cells
使用深度测序和人类 iPS 细胞分析基因组改变和肝癌发生机制
- 批准号:
19H03635 - 财政年份:2019
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of human iPS cell-derived model for hepatocarcinogenesis
人类 iPS 细胞衍生的肝癌模型的开发
- 批准号:
17K19647 - 财政年份:2017
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Comprehensive analyses of gene mutational profile and viral integration in hepatocellular carcinoma and development of novel human iPS cells-derived disease model
肝细胞癌基因突变谱和病毒整合的综合分析以及新型人类 iPS 细胞衍生疾病模型的开发
- 批准号:
16H05285 - 财政年份:2016
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Innate immunity and treatment response in chronic viral hepatitis
慢性病毒性肝炎的先天免疫和治疗反应
- 批准号:
25293169 - 财政年份:2013
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Development of a novel human NASH model using human iPS cell-derived liver organoids
使用人类 iPS 细胞衍生的肝脏类器官开发新型人类 NASH 模型
- 批准号:
23K08025 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of novel pathophysiology and development of treatment for heart failure using human iPS cell-derived 3D heart tissue
利用人 iPS 细胞衍生的 3D 心脏组织阐明新的病理生理学并开发心力衰竭治疗方法
- 批准号:
23K15140 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Generation of the transplantation model of human iPS cell-derived airway epithelial sheet into nasal cavity
人iPS细胞来源的气道上皮片鼻腔移植模型的建立
- 批准号:
23K08961 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Comprehensive study of human iPS cell-derived mitochondria transplantation therapy for practical use
人类 iPS 细胞来源的线粒体移植疗法实用化的综合研究
- 批准号:
23K18595 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A Novel Salivary Gland Regenerative Therapy Using Human iPS Cell-Derived Salivary Gland Organoids and Large-Scale Culture System
使用人类 iPS 细胞衍生的唾液腺类器官和大规模培养系统的新型唾液腺再生疗法
- 批准号:
23H03090 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of CNP dynamics of human iPS cell-derived mature cardiomyocytes
阐明人 iPS 细胞衍生的成熟心肌细胞的 CNP 动态
- 批准号:
23K08261 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a treatment for hearing loss using human iPS cell-derived otic organoids and novel antisense oligos
使用人类 iPS 细胞衍生的耳类器官和新型反义寡核苷酸开发听力损失治疗方法
- 批准号:
23K15896 - 财政年份:2023
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Retinal optic nerve regeneration by human iPS cell-derived retinal ganglion cells and artificial sieve plate transplantation
人iPS细胞来源的视网膜神经节细胞和人工筛板移植的视网膜视神经再生
- 批准号:
21K19548 - 财政年份:2021
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Elucidation of the pathophysiology of 22q11.2 deletion syndrome by visualizing human iPS cell-derived neural circuit
通过可视化人 iPS 细胞衍生的神经回路阐明 22q11.2 缺失综合征的病理生理学
- 批准号:
21K20860 - 财政年份:2021
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Mitochondrial dysfunction in human iPS cell-derived retinal ganglion cells
人 iPS 细胞来源的视网膜神经节细胞的线粒体功能障碍
- 批准号:
21K16865 - 财政年份:2021
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists